HOME >> MEDICINE >> NEWS
Vanderbilt Cancer Center Discovery May Help Overcome Resistance To Anti-Breast Cancer Drug

NASHVILLE, Tenn. -- Vanderbilt Cancer Center researchers have reported a discovery that could help overcome a major obstacle in treating breast cancer with tamoxifen -- the resistance that breast tumor cells commonly develop to this "anti-estrogen" drug.

Writing in the Jan. 6 issue of the Journal of the National Cancer Institute, the researchers report that overproduction of a certain growth factor, called TGF-beta, contributes to tamoxifen resistance. They also demonstrate that the immune system's "natural killer" activity is important for tamoxifen's anti-cancer effects.

Ultimately, both findings might be exploited to keep tumors dormant for longer periods using tamoxifen.

"At some point in the natural history of breast cancer, tumors become resistant to the anti-estrogen tamoxifen," said principal investigator Dr. Carlos L. Arteaga, professor of Medicine and associate professor of Cell Biology.

"The practical implication of this research is that, if we can sort out the mediators of this effect, perhaps we can design strategies to interfere with those mechanisms and markedly prolong the period of tamoxifen response or even reverse tamoxifen resistance."

Tamoxifen, a relatively well-tolerated therapy, has been a part of the arsenal against advanced breast cancer for more than two decades. More recently, it has been used as an additional therapy following surgery or other primary treatment for early stage breast cancer. Tamoxifen is also being studied as a "chemopreventive" to delay the onset of breast cancer in women at high risk of developing the disease.

The drug is called an anti-estrogen because it blocks the effects of the female hormone estrogen. Some breast cancer cells are sensitive to estrogen, which binds to estrogen receptors in these cells and stimulates them to proliferate and invade.

In patients with metastatic breast cancer, tumors typically become resistant to tamoxifen in about 12-18 months, Arteaga said.

Earli
'"/>

Contact: Cynthia Manley
cynthia.manley@mcmail.vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
6-Jan-1999


Page: 1 2 3

Related medicine news :

1. Childrens Hospital at Vanderbilt ranked 8th in nation by Child magazine
2. Diabetic eye screening bill based on Vanderbilt model
3. New endowed chair established at Vanderbilt to promote brain resesarch
4. Fran Visco receives Frances Williams Preston Award from Vanderbilt University
5. Special Fulbright awarded to Vanderbilt ethnomusicologist
6. Meharry-Vanderbilt partnership aims to address racial disparity in cancer outcomes
7. Vanderbilt School of Nursing begins graduate program in correctional health
8. Vanderbilt University Medical Center designated as one of three Glaxo Wellcome Genetic Epidemiology Centers
9. Cancer in patients with hepatitis C
10. Olson family donates $1 million to Arizona Cancer Center
11. Cancer vaccines: A two-pronged attack?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2018)... ... ... Ross A. Clevens, MD, FACS is excited to announce the arrival of CoolSculpting ... Clevens is known for introducing innovative techniques with a proven track record for safety ... associate, Amy Simon, MD, FACS, Dr. Clevens is proud to be the only local ...
(Date:8/11/2018)... (PRWEB) , ... August 10, 2018 , ... ... industry leader in Gout Relief. , What is gout? This painful, persistent condition ... as a result of high levels of uric acid. Other contributing factors may ...
(Date:8/11/2018)... ... August 10, 2018 , ... Georgia ... procedures to metro Atlanta. Drs. Brent Sharpe and Froylan Gonzalez recently widened that ... in Braselton. , On June 27, the physicians combined their expertise to perform ...
(Date:8/9/2018)... ... August 09, 2018 , ... ... their implants have ruptured, according to cross-referenced data from The American Society of ... gel implant rupture rates monitored by the FDA. As an MRI is recommended ...
(Date:8/9/2018)... ... August 09, 2018 , ... ... LegitScript is a new verification process that substance abuse providers must pass in ... means we can reach more people to help.” , Helping people is ...
Breaking Medicine News(10 mins):
(Date:8/3/2018)... ... August 03, 2018 , ... LifeWIRE’s innovative ... patents list of the 5,000-strong association of app companies and information technology firms ... Compliance and Notification Method System and Computer Program Product” and subsequent patents are ...
(Date:8/2/2018)... ... ... What: The Wharton School is pleased to invite business journalists to apply ... who cover aspects of public policy to attend the Wharton Seminars for Business ... cost of tuition, course materials, most group meals, lodging for three nights and airfare ...
(Date:8/2/2018)... ... August 02, 2018 , ... ... about their child’s ability to communicate. These may include concerns with speaking, listening, ... schools by a speech-language pathologist. Here’s what parents should know, according to ...
Breaking Medicine Technology:
Cached News: